Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8822)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2017 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. World J Gastroenterol 2017; 23(41): 7415-7424 [PMID: 29151695 DOI: 10.3748/wjg.v23.i41.7415] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i41/7415.htm |
| Number | Citing Articles |
| 1 |
Zhen Li, Du Xiao, Xin Li, Pengchao Zhan, Jiaxiang Wang, Henghui Zhang. Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNA. European Journal of Gastroenterology & Hepatology 2019; 31(7): 885 doi: 10.1097/MEG.0000000000001373
|
| 2 |
Zhen-Hua Chen, Xiu-Ping Zhang, Jin-Kai Feng, Le-Qun Li, Fan Zhang, Yi-Ren Hu, Cheng-Qian Zhong, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from China. Hepatology International 2021; 15(3): 642 doi: 10.1007/s12072-021-10174-x
|
| 3 |
Wenlong Song, Xiangling Yu, Dajing Guo, Huan Liu, Zhuoyue Tang, Xinjie Liu, Jun Zhou, Haiping Zhang, Yangyang Liu, Xi Liu. MRI‐Based Radiomics: Associations With the Recurrence‐Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization. Journal of Magnetic Resonance Imaging 2020; 52(2): 461 doi: 10.1002/jmri.26977
|
| 4 |
Derek J. Erstad, Kenneth K. Tanabe. ASO Author Reflections: A New Look at the Clinical Significance of MVI in Hepatocellular Carcinoma. Annals of Surgical Oncology 2019; 26(S3): 617 doi: 10.1245/s10434-019-07364-1
|
| 5 |
Lei Wang, Qiao Ke, Kongying Lin, Jingbo Chen, Ren Wang, Chunhong Xiao, Xiaolong Liu, Jingfeng Liu. <p>Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study</p>. Cancer Management and Research 2020; : 3815 doi: 10.2147/CMAR.S251605
|
| 6 |
Zhi-Xi Li, Qi-Fan Zhang, Jia-Ming Huang, Shao-Jian Huang, Han-Biao Liang, Hao Chen, Zhan-Hong Lai, Qing-Yan Li, Jian-Ping Qian, Kai Wang, Jie Zhou. Safety and efficacy of postoperative adjuvant therapy with atezolizumab and bevacizumab after radical resection of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102165 doi: 10.1016/j.clinre.2023.102165
|
| 7 |
Kaiquan Huang, Tao Qian, Wen Chen, Mengyi Lao, Huiliang Li, Wei-Chiao Lin, Bryan Wei Chen, Xueli Bai, Shunliang Gao, Tao Ma, Tingbo Liang. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12396-2
|
| 8 |
Shuang Liu, Hui Li, Lei Guo, Bo Zhang, Binghai Zhou, Wentao Zhang, Jian Zhou, Jia Fan, Qinghai Ye. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion. The Oncologist 2019; 24(4): 513 doi: 10.1634/theoncologist.2018-0305
|
| 9 |
Zhen-Hua Chen, Xiu-Ping Zhang, Hang Wang, Zong-Tao Chai, Ju-Xian Sun, Wei-Xing Guo, Jie Shi, Shu-Qun Cheng. Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis. HPB 2019; 21(8): 935 doi: 10.1016/j.hpb.2019.02.003
|
| 10 |
Zhi-Ming Zeng, Ning Mo, Jie Zeng, Fu-Chao Ma, Yan-Feng Jiang, Hua-Sheng Huang, Xi-Wen Liao, Guang-Zhi Zhu, Jie Ma, Tao Peng. Advances in postoperative adjuvant therapy for primary liver cancer. World Journal of Gastrointestinal Oncology 2022; 14(9): 1604-1621 doi: 10.4251/wjgo.v14.i9.1604
|
| 11 |
Lei Liang, Chao Li, Yong-Kang Diao, Hang-Dong Jia, Hao Xing, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Dong-Sheng Huang, Cheng-Wu Zhang, Tian Yang. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820977693
|
| 12 |
Xizhu Xu, Rui Chen, Qingmei Chen, Kang An, Lu Ding, Le Zhang, Fang Wang, Yang Deng. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study. Complementary Therapies in Clinical Practice 2021; 43: 101359 doi: 10.1016/j.ctcp.2021.101359
|
| 13 |
Shuqi Mao, Yuying Shan, Xi Yu, Jing Huang, Jiongze Fang, Min Wang, Rui Fan, Shengdong Wu, Caide Lu. A new prognostic model predicting hepatocellular carcinoma early recurrence in patients with microvascular invasion who received postoperative adjuvant transcatheter arterial chemoembolization. European Journal of Surgical Oncology 2023; 49(1): 129 doi: 10.1016/j.ejso.2022.08.013
|
| 14 |
Xu Feng, Guo-Ying Feng, Jie Tao, Yu-Pei Ao, Xin-Hua Wu, Shi-Guai Qi, Zheng-Rong Shi. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(12): 10505 doi: 10.1007/s00432-023-04874-0
|
| 15 |
Han Wang, Meng‐Chao Wu, Wen‐Ming Cong. Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis. Hepatology Research 2019; 49(3): 344 doi: 10.1111/hepr.13241
|
| 16 |
Anwei Mo, Biquan Lin, Denglin Chen. Efficacy of sequential TACE on primary hepatocellular carcinoma with microvascular invasion after radical resection: a systematic review and meta-analysis. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-03160-0
|
| 17 |
Jie Tao, Xiaoli Shi, Xu Feng, Xinhua Wu, Shiguai Qi, Guoying Feng, Xu Yang, Yufei Zhao, Hangjia Zuo, Zhengrong Shi. Development and Validation of a Risk Prediction Algorithm for
Evaluating the Efficacy of Postoperative Adjuvant TACE Therapy for
Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2024; 27(8): 1111 doi: 10.2174/1386207326666230824090204
|
| 18 |
Ai Shen, Miao Liu, Daofeng Zheng, Qingsong Chen, Zhongjun Wu. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): 142 doi: 10.1016/j.clinre.2019.06.012
|
| 19 |
Yunyun Wei, Wei Pei, Yunying Qin, Danke Su, Hai Liao. Preoperative MR imaging for predicting early recurrence of solitary hepatocellular carcinoma without microvascular invasion. European Journal of Radiology 2021; 138: 109663 doi: 10.1016/j.ejrad.2021.109663
|
| 20 |
Shu‐Wen Sun, Qiu‐Ping Liu, Xun Xu, Fei‐Peng Zhu, Yu‐Dong Zhang, Xi‐Sheng Liu. Direct Comparison of Four Presurgical Stratifying Schemes for Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Gadoxetic Acid‐Enhanced MRI. Journal of Magnetic Resonance Imaging 2020; 52(2): 433 doi: 10.1002/jmri.27043
|
| 21 |
Laihui Luo, Renfeng Shan, Lifeng Cui, Zhao Wu, Junlin Qian, Shuju Tu, WenJian Zhang, Yuanpeng Xiong, Wei Lin, Hongtao Tang, Yang Zhang, Jisheng Zhu, Zeyu Huang, Zhigang Li, Shengping Mao, Hui Li, Zemin Hu, Peng Peng, Kun He, Yong Li, Liping Liu, Wei Shen, Yongzhu He. Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort. United European Gastroenterology Journal 2023; 11(2): 228 doi: 10.1002/ueg2.12365
|
| 22 |
Xiu-Ping Zhang, Yan-Chen Liu, Zhen-Hua Chen, Ju-Xian Sun, Kang Wang, Zong-Tao Chai, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis. Annals of Surgical Oncology 2019; 26(5): 1465 doi: 10.1245/s10434-019-07223-z
|
| 23 |
Ana-Maria Ciurea, Dan Ionuț Gheonea, Michael Schenker, Alina Maria Mehedințeanu, Georgică Costinel Târtea, Cristin Constantin Vere. The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular Carcinoma. Diagnostics 2021; 11(5): 890 doi: 10.3390/diagnostics11050890
|
| 24 |
Shinichiro Nakada, Marc-Antoine Allard, Maite Lewin, Sameh Awad, Nour Dahbi, Hidetoshi Nitta, Antonio Sa Cunha, Denis Castaing, Eric Vibert, Daniel Cherqui, Masaru Miyazaki, Masayuki Ohtsuka, René Adam. Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication. Journal of Gastrointestinal Surgery 2020; 24(11): 2517 doi: 10.1007/s11605-019-04409-4
|
| 25 |
Feng-Yong Liu, Xin Li, Hong-Jun Yuan, Yang Guan, Mao-Qiang Wang. Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization. Chinese Medical Journal 2018; 131(20): 2410 doi: 10.4103/0366-6999.243554
|
| 26 |
Centura R. Anbarasu, Sophia Williams-Perez, Ernest R. Camp, Derek J. Erstad. Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Cancers 2024; 16(16): 2773 doi: 10.3390/cancers16162773
|
| 27 |
Liang Sun, Pi-Bao Li, Yan-Fen Yao, Ai-Yuan Xiu, Zhi Peng, Yu-Huan Bai, Yan-Jing Gao. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(10): 1120-1133 doi: 10.3748/wjg.v24.i10.1120
|
| 28 |
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung, Jordan M Cloyd. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(28): 3704-3721 doi: 10.3748/wjg.v25.i28.3704
|
| 29 |
Xiu-Ping Zhang, Zong-Tao Chai, Yu-Zhen Gao, Zhen-Hua Chen, Kang Wang, Jie Shi, Wei-Xing Guo, Teng-Fei Zhou, Jin Ding, Wen-Ming Cong, Dong Xie, Wan Y. Lau, Shu-Qun Cheng. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis. HPB 2019; 21(12): 1687 doi: 10.1016/j.hpb.2019.04.014
|
| 30 |
Jeng-Shiun Du, Shih-Hsien Hsu, Shen-Nien Wang. The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma. Cancers 2024; 16(7): 1422 doi: 10.3390/cancers16071422
|
| 31 |
Soon Kyu Lee, Myeong Jun Song, Seok Hwan Kim, Misun Park, Ming-Lung Yu. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study. PLOS ONE 2019; 14(5): e0216173 doi: 10.1371/journal.pone.0216173
|
| 32 |
Tongshan Wang, Jun Liu, Suihui Li, Zhengang Yuan, Xiangzhong Huang. Effects of knockout of lincRNA‑p21 on the proliferation, migration and invasion ability of HepG2 liver cancer cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10201
|
| 33 |
Han Wang, Hua Yu, You-Wen Qian, Zhen-Ying Cao, Meng-Chao Wu, Wen-Ming Cong. Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2021; 20(3): 232 doi: 10.1016/j.hbpd.2020.12.018
|
| 34 |
Liang Xiao, Furong Zeng, Guangtong Deng. Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma. Bioscience Reports 2019; 39(10) doi: 10.1042/BSR20190683
|
| 35 |
Andrew K.Y. Fung, Nicole M.Y. Cheng, Charing C.N. Chong, Kit-Fai Lee, John Wong, Sunny Y.S. Cheung, Hon-Ting Lok, Paul B.S. Lai, Kelvin K.C. Ng. Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy. Medicine 2020; 99(48): e23358 doi: 10.1097/MD.0000000000023358
|
| 36 |
Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai, Tingbo Liang. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma. HPB 2020; 22(6): 795 doi: 10.1016/j.hpb.2019.12.013
|
| 37 |
Zehao Zheng, Renguo Guan, Wang Jianxi, Zhen Zhao, Tianyi Peng, Chunsheng Liu, Ye Lin, Zhixiang Jian, Yuan Seng Wu. Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/9567041
|
| 38 |
Lian Li, Bo Li, Ming Zhang. Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis. Acta Radiologica 2020; 61(6): 723 doi: 10.1177/0284185119878357
|
| 39 |
Qiao Ke, Fu Xiang, Chunhong Xiao, Qizhen Huang, Xiaolong Liu, Yongyi Zeng, Lei Wang, Jingfeng Liu. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08843-z
|
| 40 |
Xiu-Ping Zhang, Kang Wang, Xu-Biao Wei, Le-Qun Li, Hui-Chuan Sun, Tian-Fu Wen, Zong-Tao Chai, Zhen-Hua Chen, Jie Shi, Wei-Xing Guo, Dong Xie, Wen-Ming Cong, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study. The Oncologist 2019; 24(12): e1476 doi: 10.1634/theoncologist.2018-0868
|
| 41 |
Xue-Fen Lei, Yang Ke, Tian-Hao Bao, Hao-Ran Tang, Xue-Song Wu, Zhi-Tian Shi, Jie Lin, Zhi-Xian Zhang, Hou Gu, Lin Wang. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World Journal of Clinical Cases 2018; 6(5): 74-83 doi: 10.12998/wjcc.v6.i5.74
|
| 42 |
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
|
| 43 |
Yu-Qing Yang, Zhen-Yu Wen, Xiao-Yan Liu, Zhen-Hu Ma, Yan-E Liu, Xue-Ying Cao, Li Hou, Hui Xie. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World Journal of Hepatology 2023; 15(2): 129-150 doi: 10.4254/wjh.v15.i2.129
|
| 44 |
Lei Wang, Qiao Ke, Nanping Lin, Yongyi Zeng, Jingfeng Liu. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis. Scandinavian Journal of Gastroenterology 2019; 54(5): 528 doi: 10.1080/00365521.2019.1610794
|
| 45 |
Xiulin Xiao, Lin Zhou, Long Zhang, Zhiyuan Xu, Qixin Dai, Xiaohong Deng, Weiguo Li. Short-Term and Long-Term Curative Effect of Partial Hepatectomy on Ruptured Hemorrhage of Primary Liver Cancer after TAE. Emergency Medicine International 2022; 2022: 1 doi: 10.1155/2022/2484418
|
| 46 |
Qizhen Huang, Kongying Lin, Lei Wang, Jianxing Zeng, Hongzhi Liu, Zongren Ding, Yongyi Zeng, Jingfeng Liu. <p>Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study</p>. Cancer Management and Research 2020; : 9183 doi: 10.2147/CMAR.S270467
|
| 47 |
Shang-Dong Qin, Jie Zhang, Ya-Peng Qi, Jian-Hong Zhong, Bang-De Xiang. Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomy. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02632-z
|
| 48 |
Guifang Zeng, Baojia Zou, Yongliang Li, En Lin, Xialei Liu, Peiping Li, Jiafan Chen, Baimeng Zhang, Yingbin Jia, Chaonong Cai, Jian Li. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study. Journal of Investigative Surgery 2022; 35(6): 1208 doi: 10.1080/08941939.2021.2021334
|
| 49 |
Jia-Hui Lv, Wei-Zhao Chen, Yi-Nan Li, Jin-Xiu Wang, Yang-Kai Fu, Zhen-Xin Zeng, Jia-Yi Wu, Shuang-Jia Wang, Xiao-Xiao Huang, Li-Ming Huang, Rong-Fa Huang, Yong-Gang Wei, Mao-Lin Yan. Should associating liver partition and portal vein ligation for staged hepatectomy be applied to hepatitis B virus-related hepatocellular carcinoma patients with cirrhosis? A multi-center study. HPB 2022; 24(12): 2175 doi: 10.1016/j.hpb.2022.10.001
|
| 50 |
Yanan Jiang, Xiuyun Shen, Moyondafoluwa Blessing Fasae, Fengnan Zhi, Lu Chai, Yue Ou, Hai Feng, Siwei Liu, Ying Liu, Shucai Yang, Maria Isaguliants. The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/4044606
|
| 51 |
Juqiang Zhang, Hao Peng, Botian Wang, Lei Luo, Yuan Cheng, Guolin He, Yujun Tang, MingXin Pan. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell. Journal of Gastrointestinal Surgery 2021; 25(7): 1770 doi: 10.1007/s11605-020-04755-8
|
| 52 |
Yong Zhu He, Kun He, Rui Qin Huang, Ze Liang Wang, Shao Wei Ye, Li Wen Liu, Qi Jie Luo, Ze Min Hu. Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis. Annals of Hepatology 2020; 19(6): 654 doi: 10.1016/j.aohep.2020.07.002
|
| 53 |
Lian Li, Bo Li, Ming Zhang. HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasion. Medicine 2019; 98(27): e16308 doi: 10.1097/MD.0000000000016308
|
| 54 |
Zhen-Hua Chen, Xiu-Ping Zhang, Jin-Kai Feng, Le-Qun Li, Fan Zhang, Yi-Ren Hu, Cheng-Qian Zhong, Kang Wang, Zong-Tao Chai, Xu-Biao Wei, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Y. Lau, Shu-Qun Cheng. Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China. HPB 2022; 24(7): 1063 doi: 10.1016/j.hpb.2021.11.016
|
| 55 |
Jiarui Yang, Hao Liang, Kunpeng Hu, Zhiyong Xiong, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao, Meihai Deng. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01790-6
|
| 56 |
Derek J. Erstad, Kenneth K. Tanabe. Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. Annals of Surgical Oncology 2019; 26(5): 1474 doi: 10.1245/s10434-019-07227-9
|
| 57 |
Zhen-Hua Chen, Xiu-Ping Zhang, Teng-Fei Zhou, Kang Wang, Hang Wang, Zong-Tao Chai, Jie Shi, Wei-Xing Guo, Shu-Qun Cheng. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis. European Journal of Surgical Oncology 2019; 45(11): 2188 doi: 10.1016/j.ejso.2019.06.031
|
| 58 |
Kevin P. Labadie, Jonathan G. Sham. Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for Everybody. Annals of Surgical Oncology 2020; 27(11): 4070 doi: 10.1245/s10434-020-08702-4
|
| 59 |
Naoya Sato, Shigeru Marubashi. What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?. Surgery Today 2022; 52(6): 871 doi: 10.1007/s00595-021-02352-z
|
| 60 |
Leyao Wang, Meng Liang, Bing Feng, Dengfeng Li, Rong Cong, Zhaowei Chen, Sicong Wang, Xiaohong Ma, Xinming Zhao. Microvascular invasion-negative hepatocellular carcinoma: Prognostic value of qualitative and quantitative Gd-EOB-DTPA MRI analysis. European Journal of Radiology 2023; 168: 111146 doi: 10.1016/j.ejrad.2023.111146
|
| 61 |
粟 王. Advances in the Treatment of Microvascular Invasion in Hepatocellular Carcinoma. Journal of Clinical Personalized Medicine 2024; 3(01): 47 doi: 10.12677/JCPM.2024.31008
|
| 62 |
Zhan-Qi Wei, Yue-Wei Zhang. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit. Chinese Medical Journal 2021; 134(19): 2275 doi: 10.1097/CM9.0000000000001767
|
| 63 |
Jiang Li, Fan Yang, Jian Li, Zhi-Yong Huang, Qi Cheng, Er-Lei Zhang. Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion. World Journal of Gastrointestinal Surgery 2023; 15(1): 19-31 doi: 10.4240/wjgs.v15.i1.19
|
| 64 |
Chao Li, Ming-Da Wang, Lun Lu, Han Wu, Jiong-Jie Yu, Wan-Guang Zhang, Timothy M. Pawlik, Yao-Ming Zhang, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Jun Han, Hao Xing, Zhen-Li Li, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis. Hepatology International 2019; 13(6): 736 doi: 10.1007/s12072-019-09981-0
|